Industry

– Promising Results Support Further Development of LinearDNA as a Next Generation Vaccine Platform – STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #LinearDNA—Applied DNA Sciences, Inc. (NASDAQ: APDN) (‘Applied DNA’ or the “Company”), a leader in polymerase chain reaction (PCR”)-based technologies, today announced the publication of a manuscript, co-authored with international academic and industry scientists, containing data demonstrating … [Read more…]

The “Believe it!” Campaign Will be Featured on TV Networks and Radio Stations Across the U.S., Driving Viewers to SCDBelieveIT.org HANOVER, MD and WATERTOWN, Mass.–(BUSINESS WIRE)–The Sickle Cell Disease Association of America, Inc. (SCDAA), in partnership with Forma Therapeutics, Inc. (Nasdaq: FMTX) today announced that they have joined forces to create a public service announcement … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Smart Pulse Oximeters Market By Type, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering. The smart pulse oximeters market was valued at $1,639.19 million in 2021 and is expected to reach $3,453.29 million by 2031, growing at a CAGR of 7.7% from 2022 to … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Companion Diagnostics Market 2022-2028” report has been added to ResearchAndMarkets.com’s offering. Market Outlook Based on this report, the global companion diagnostics market is projected to progress with a CAGR of 12.84% during the forecast period 2022-2028. The prominent factors fueling the global market’s growth include a surge in medication reaction incidence, increasing … [Read more…]

DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced the appointment of Joshua (“Josh”) Wilson to its Board of Directors, effective September 30, 2022, with a term ending concurrently with the Company’s 2024 annual stockholders’ meeting. Mr. Wilson … [Read more…]

RNA synthesis platform to target synthesis lengths greater than 100-nt, large-scale GMP manufacturing, and novel therapeutic modifications in collaboration with industry partners Advanced-stage technology with over six years of development at the Wyss Institute at Harvard University, co-founded by Dr. George Church of Harvard Medical School, and the first spin-out from the Northpond Labs Alliance … [Read more…]

TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), has reached an agreement with the Attorney General (AG) of Georgia to settle the state’s price-fixing claims against Teva. Teva will pay the state $3.346 million as part of the settlement, and the state will … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Immunotherapy Market Research and Forecast, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. The global immunotherapy market is growing at a CAGR of 13.8% during the forecast period (2021-2027). The major factors that are augmenting the growth of the immunotherapy market includes increasing prevalence of auto-immune diseases among adults and increasing investments … [Read more…]

More than 80 pastors aim to reach congregants in Oct. 9 sermons in honor of World Mental Health Day CHICAGO–(BUSINESS WIRE)–Faith leaders from more than 80 Black churches in Chicago met on September 29, 2022, to discuss mental health stigma and learn how to better minister to mental health concerns among their congregants. The forum, … [Read more…]

TORONTO–(BUSINESS WIRE)–NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today provided an update on leadership changes, as well as its strategic growth plan to significantly accelerate the growth of its best-in-class and coordinated continuum of care for patients across Canada who suffer … [Read more…]